Merceditas Villanueva
Biographic Data
| ID | 7450737 |
|---|---|
| NAME | Merceditas Villanueva |
| GIVEN NAMES | Merceditas |
| FAMILY NAME | Villanueva |
| SIGNATURE | VILLANUEVA M |
| AFFILIATIONS | Yale University |
| ORCID | 0000-0003-1022-7746 |
| VERIFIED | Yes |
| TOTAL WORKS | 6 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 6 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Disease Intervention Specialist Field Experience in Re-engaging Out-of-Care People with HIV in Project CoRect
Using the exploration, preparation, implementation, sustainment (Epis) framework to assess the cooperative re-engagement controlled trial (CoRect)
Background: "Data to Care" (D2C) is a strategy which relies on a combination of public health surveillance data supplemented by clinic data to support continuity of HIV care. The Cooperative Re-Engagement Controlled Trial (CoRECT) was a CDC-sponsored randomized controlled trial of a D2C model, which provided an opportunity to examine the process of implementing an intervention for people with HIV (PWH) who are out-of-care across three public heal…
Prevalence and Correlates of Physical Inactivity Among Individuals with HIV During the First Covid-19 Wave
Perceptions Towards HCV Treatment with Direct Acting Antivirals (DAAs)
In the United States, approximately 25% of people with HIV (PWH) are co-infected with hepatitis C (HCV). Since 2014, highly effective and well-tolerated direct-acting antivirals (DAAs) have revolutionized HCV treatment. Uptake of DAAs by people with HIV/HCV co-infection has improved but remains suboptimal due to system, provider, and patient-level barriers. To explore patient-level issues by better understanding their attitudes towards DAA treatm…
Experiences with Telemedicine for HIV Care During the Covid-19 Pandemic
Treatment of Hepatitis C virus among people who inject drugs at a syringe service program during the Covid-19 response
No prominent works on this page.
Perceptions Towards HCV Treatment with Direct Acting Antivirals (DAAs)
In the United States, approximately 25% of people with HIV (PWH) are co-infected with hepatitis C (HCV). Since 2014, highly effective and well-tolerated direct-acting antivirals (DAAs) have revolutionized HCV treatment. Uptake of DAAs by people with HIV/HCV co-infection has improved but remains suboptimal due to system, provider, and patient-level barriers. To explore patient-level issues by better understanding their attitudes towards DAA treatm…
Experiences with Telemedicine for HIV Care During the Covid-19 Pandemic
Treatment of Hepatitis C virus among people who inject drugs at a syringe service program during the Covid-19 response
Using the exploration, preparation, implementation, sustainment (Epis) framework to assess the cooperative re-engagement controlled trial (CoRect)
Background: "Data to Care" (D2C) is a strategy which relies on a combination of public health surveillance data supplemented by clinic data to support continuity of HIV care. The Cooperative Re-Engagement Controlled Trial (CoRECT) was a CDC-sponsored randomized controlled trial of a D2C model, which provided an opportunity to examine the process of implementing an intervention for people with HIV (PWH) who are out-of-care across three public heal…
Prevalence and Correlates of Physical Inactivity Among Individuals with HIV During the First Covid-19 Wave
Disease Intervention Specialist Field Experience in Re-engaging Out-of-Care People with HIV in Project CoRect
Medicine (6 works) · Internal Medicine (5 works) · Nursing (5 works) · Health care (4 works) · HIV/AIDS Research and Interventions (4 works) · Public health (4 works) · Coronavirus disease 2019 (COVID-19 (3 works) · Family medicine (3 works) · Health psychology (3 works) · HIV, Drug Use, Sexual Risk (3 works)